Table 5.
Performance of non-invasive markers for prediction of esophageal variceal bleeding (n = 34)
| Non-invasive markers | Cut-off value | Sensitivity | Specificity | AUC (95%CI)1 | P value |
| FIB-4 | 5.02 | 53% | 54% | 0.51 (0.40-0.62) | 0.881 |
| Fibrosis index | 3.12 | 53% | 45% | 0.52 (0.40-0.61) | 0.901 |
| King score | 37.16 | 65% | 44% | 0.50 (0.40-0.60) | 0.978 |
| APRI | 1.66 | 59% | 54% | 0.53 (0.43-0.64) | 0.550 |
| PL/SD | 828 | 53% | 39% | 0.45 (0.34-0.56) | 0.398 |
| AST/ALT | 1.71 | 59% | 54% | 0.53 (0.42-0.64) | 0.628 |
| MELD | 15.5 | 56% | 52% | 0.55 (0.44-0.65) | 0.436 |
1
AUC (area under the curve) obtained from the receiver operating characteristic. AST/ALT: Aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio; APRI: AST to platelet ratio index; FIB-4: Fibrosis-4-index; MELD: Model for end-stage liver disease; PC/SD: Platelet count to spleen diameter.